Kala Bio (KALA) Change in Accured Expenses (2016 - 2026)

Kala Bio has reported Change in Accured Expenses for 11 years, with the latest figure at -$995000.0 in Q1 2026.

• Quarterly Change in Accured Expenses fell 12.94% year-over-year to -$995000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.0 million (down 1535.51% YoY) and the FY2025 annual result came in at -$3.9 million, down 154.78% from the prior year.
• Change in Accured Expenses climbed to -$995000.0 in Q1 2026 per KALA's latest filing, from -$1.3 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $7.2 million in Q3 2022 and troughed at -$16.5 million in Q4 2022.
• A 5-year average of -$1.2 million and a median of -$984000.0 in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses sank 1476.99% in 2023, then soared 804.94% in 2024.
• Over 5 years, Change in Accured Expenses stood at -$16.5 million in 2022, then jumped by 87.22% to -$2.1 million in 2023, then jumped by 135.0% to $736000.0 in 2024, then tumbled by 278.4% to -$1.3 million in 2025, then climbed by 24.22% to -$995000.0 in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$995000.0, -$1.3 million, and -$984000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.